Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Change in Inventory (2023 - 2025)

Fennec Pharmaceuticals' Change in Inventory history spans 3 years, with the latest figure at -$139000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 113.85% year-over-year to -$139000.0, compared with a TTM value of $1.3 million through Dec 2025, up 320.73%, and an annual FY2025 reading of $1.3 million, up 320.73% over the prior year.
  • Change in Inventory for Q4 2025 was -$139000.0 at Fennec Pharmaceuticals, down from $276000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $797000.0 in Q2 2025, with the low at -$502000.0 in Q3 2024.
  • Average Change in Inventory over 3 years is $189916.7, with a median of $296000.0 recorded in 2023.
  • Year-over-year, Change in Inventory plummeted 258.86% in 2024 and then skyrocketed 896.25% in 2025.
  • Tracing FENC's Change in Inventory over 3 years: stood at $401000.0 in 2023, then tumbled by 116.21% to -$65000.0 in 2024, then crashed by 113.85% to -$139000.0 in 2025.
  • Per Business Quant, the three most recent readings for FENC's Change in Inventory are -$139000.0 (Q4 2025), $276000.0 (Q3 2025), and $797000.0 (Q2 2025).